[Problems in measuring the activity of alpha 2-plasmin inhibitor in the urokinase therapy].
D001793:Blood Preservation; D002544:Cerebral Infarction / Q000097:blood / Q000628:therapy; D006801:Humans; D010958:Plasminogen / Q000378:metabolism; D013696:Temperature; D014568:Urokinase-Type Plasminogen Activator / Q000097:blood / Q000627:therapeutic use*; D000979:alpha-2-Antiplasmin / Q000378:metabolism*
D000979:alpha-2-Antiplasmin; D010958:Plasminogen; D014568:Urokinase-Type Plasminogen Activator